Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Vaccine-Injured Families and Their Doctors Change the Minds of Directors at the Medical Board of California

Physicians for Informed Consent advocates for vaccine-injured families, urges opposition to California Vaccine Bill SB 276.


News provided by

Physicians for Informed Consent

Jun 18, 2019, 16:00 ET

Share this article

Share toX

Share this article

Share toX

Youtube
Youtube

NEWPORT BEACH, Calif., June 18, 2019 /PRNewswire-PRWeb/ -- An unexpected and overwhelming public outcry at the May 28, 2019, quarterly meeting of the Medical Board of California (MBC) led some of its directors to change their minds about supporting SB 276, the bill currently at the California Assembly that would prevent doctors from being able to protect their patients from vaccine injuries. After hearing testimony from hundreds of parents, as well as physicians, Dr. Randy Hawkins rescinded his initial support of SB 276: "I withdraw my second. I've reconsidered. I was impressed by the amount of concern from the public, and I thought I decided before I came in, but I've gotten some literature and that makes me rethink it…"[1]

Dr. Felix Yip voted against SB 276 and stated, "…listening to the public and reading the literature…I'm not sure how many amendments we'd need to make in order to support this bill with amendments; you'd pretty much have to change the whole bill."

“If SB 276 passes, the California families who need them most will no longer be able to effectively access the doctors who are best able to protect them from vaccine injuries,” explains Dr. Miller.

Post this

PIC Founder and President Dr. Shira Miller spoke at the meeting and submitted written testimony that explains how SB 276 contradicts the MBC's mission to protect patients and promote patient access to quality care.[2] Dr. Miller writes, "Since the National Childhood Vaccine Injury Act of 1986, which indemnifies both vaccine manufacturers and physicians from liability for vaccine injuries, and the creation of the National Vaccine Injury Compensation Program, which has awarded about $4 billion in compensation to only one-third of petitioners, it has mostly been those families with a history of vaccine injuries and their physicians who have had a heightened awareness of their risk of suffering more vaccine injuries." Less than 1% of schoolchildren have obtained medical exemptions in California, after their doctor determined that their risk of vaccine injury exceeds the benefit of a vaccine(s)—but there are only a small number of physicians who are skilled at meeting this public healthcare need. "If SB 276 passes, the California families who need them most will no longer be able to effectively access the doctors who are best able to protect them from vaccine injuries," explains Dr. Miller.

The risk of seizure after the measles, mumps and rubella (MMR) vaccine is about 1 in 250 in siblings of children with a history of febrile seizures[3] (and 5% of those would develop epilepsy[4]). Although SB 277, which passed in 2015, permits a physician to exempt such a sibling from the MMR vaccine, Centers for Disease Control and Prevention guidelines and SB 276 would not.

In terms of measles, before the measles vaccine was introduced in 1963, there was a 1 in 10,000 (0.01%) chance of dying from measles (that's about the same as one's lifetime chance of being struck by lightning), not 1 in 1,000, which is the often-publicized misrepresentation of historical data.[5] In addition, three treatments are available to help prevent the rare severe complication: Vitamin A, immune globulin, and the antiviral medication, ribavirin.[6,7,8,9]

Because the facts of SB 276 are often misrepresented, PIC has written the California Assembly Health Committee a letter that clearly explains the facts, and has also developed an informational document entitled "SB 276 Myths vs. Facts: Setting the Record Straight" to help the public gain a deeper understanding of the issues involved with this bill, which threatens public health. Click here to read it.

Physicians for Informed Consent is a nationally recognized 501(c)(3) nonprofit educational organization representing doctors and scientists whose mission is to safeguard informed consent in vaccination. In addition, PIC's Coalition for Informed Consent consists of more than 150 U.S. and international organizations. Visit physiciansforinformedconsent.org for more information.

References
1. https://youtu.be/jItwZh4dajY
2. https://physiciansforinformedconsent.org/physicians-for-informed-consent-testimony-urges-medical-board-of-california-to-oppose-sb-276/
3. https://www.ncbi.nlm.nih.gov/pubmed/15265850
4. https://academic.oup.com/aje/article/165/8/911/184889
5. https://physiciansforinformedconsent.org/government-doctors-make-gross-errors-concerning-measles-statistics-misinform-senators-threaten-public-health/
6. https://physiciansforinformedconsent.org/measles/dis/
7. https://www.ncbi.nlm.nih.gov/pubmed/22480102
8. https://www.ncbi.nlm.nih.gov/pubmed/7008941
9. https://www.ncbi.nlm.nih.gov/pubmed/23629813

SOURCE Physicians for Informed Consent

Related Links

https://physiciansforinformedconsent.org/

Modal title

View PDF

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.